Fingerprint
Dive into the research topics of 'Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: Cohort B of the phase II KEYNOTE-086 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically